Chinwag - Autumn 2019

Corporate news

Our plans get the go-ahead

And our exciting plans continue to make pace with the additional news that we were also awarded £25 million by the Research England UK Research Partnership Investment Fund (UKRPIF). The new research facility, currently known as the Paterson Redevelopment Project (PRP), will be built at The Christie on the site of the old Paterson building, which suffered fire damage in April 2017, displacing over 300 scientists and support staff. The PRP is a multi-million pound development led by The Christie on behalf of the Manchester Cancer Research Centre (MCRC), an internationally renowned partnership between The University of Manchester, Cancer Research UK and The Christie. In 2018, the partnership announced its ambitious plans for the future of the site, which is now being part Our plans to create a globally leading cancer research centre moved forward in August after Manchester City Council’s planning and highways committee members voted in support of the planning application for the redevelopment of the Paterson building. This decision will now go back to planning officers ahead of a final decision which will be issued in September.

£25m funding boost: an artist’s impression of what the new centre could look like

next wave of incredible research to better prevent, diagnose and treat cancer with the highest calibre of basic and translational science.” Construction works will start on the new building in the next few months. For further information go to www.christie.nhs.uk/about-us/ our-future/our-developments/ development-of-the-paterson-site/

funded through Round 6 of Research England’s flagship capital investment scheme, the UKRPIF. The new development will be a major step forward in realising MCRC’s ambition of becoming one of the world’s top five centres for basic, translational and clinical cancer research. It will also enable research growth, as well as facilitating a ground-breaking approach to how research partnerships work together by embedding the facility within a cancer hospital. Professor Rob Bristow, Director of MCRC, explains: “Receiving planning permission is an important milestone in this project and means we can move onto developing our plans in finer detail and really make progress. Coupled with the recent investment injection, it is really fantastic news. This new build is a manifestation of Manchester’s ambition to create the

Professor Rob Bristow

7